Chronic Fibrosing Interstitial Lung Disease
Chronic fibrosing interstitial lung disease (ILD) refers to a group of conditions in which lung tissue gradually scars and stiffens. The scarring, known as fibrosis, reduces the lungs’ ability to transfer oxygen into the bloodstream. Over time, the damage accumulates and is generally irreversible, making early recognition important.
Key points
- Repeated cycles of inflammation and repair, triggered by the immune system or an environmental factor, leave lung tissue permanently scarred.
- Idiopathic pulmonary fibrosis and fibrosis linked to autoimmune disorders such as rheumatoid arthritis are among the recognised subtypes.
- A steadily worsening cough and breathlessness on exertion are the hallmark signs, confirmed by CT imaging and lung function tests.
- Antifibrotic drugs like nintedanib aim to slow further scarring rather than reverse damage already done, alongside rehabilitation and oxygen support.
How progressive lung fibrosis develops and is managed
Most forms of fibrosing ILD share a common pattern: the immune system or an environmental trigger sets off repeated cycles of inflammation and repair that leave fibrous scar tissue behind. Common subtypes include idiopathic pulmonary fibrosis (IPF) and fibrosis occurring alongside autoimmune conditions such as rheumatoid arthritis or systemic sclerosis.
Persistent dry cough and exertional breathlessness that steadily worsens are the hallmark symptoms. A respiratory specialist typically confirms the diagnosis using high-resolution CT imaging and lung function testing.
Antifibrotic therapy aims to slow the rate of fibrosis rather than reverse existing damage. Nintedanib is one of the established antifibrotic agents used in this setting; it belongs to the broader field of respiratory health medicines targeting disease progression. Pulmonary rehabilitation, breathing exercises, and supplemental oxygen support quality of life alongside drug treatment.
Anyone experiencing progressive breathlessness or a new persistent cough that does not resolve should seek specialist respiratory assessment promptly.